Stock DNA GINKGO BIOWORKS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Ginkgo Bioworks Holdings, Inc.

Equities

DNA

US37611X1000

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-31 pm EDT 		5-day change 1st Jan Change
0.5285 USD -5.51% Intraday chart for Ginkgo Bioworks Holdings, Inc. -20.06% -68.73%
May. 30 Transcript : Ginkgo Bioworks Holdings, Inc. Presents at 2024 Leerink Partners Healthcare Crossroads Conference, May-30-2024 10:40 AM
May. 22 Transcript : Ginkgo Bioworks Holdings, Inc. Presents at TD. Cowen Virtual Sustainability & Energy Transition Summit, May-22-2024 03:25 PM

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Transcript : Ginkgo Bioworks Holdings, Inc. Presents at 2024 Leerink Partners Healthcare Crossroads Conference, May-30-2024 10:40 AM
Transcript : Ginkgo Bioworks Holdings, Inc. Presents at TD. Cowen Virtual Sustainability & Energy Transition Summit, May-22-2024 03:25 PM
Ginkgo Bioworks Holdings Insider Bought Shares Worth $514,750, According to a Recent SEC Filing
BTIG Downgrades Ginkgo Bioworks Holdings to Sell From Neutral, Price Target is $0.50
Morgan Stanley Trims Ginkgo Bioworks Price Target to $1 From $2, Maintains Equal Weight Rating
Ginkgo Bioworks to Participate in Two Conferences in May
Sojitz Corporation and Ginkgo Bioworks Announce Plans to Use Synthetic Biology R&D Services to Accelerate Sustainable Manufacturing in Japan
Ginkgo Bioworks Holdings Insider Bought Shares Worth $271,815, According to a Recent SEC Filing
Ginkgo Bioworks Holdings Insider Sold Shares Worth $1,606,162, According to a Recent SEC Filing
Ginkgo Bioworks Gets NYSE Noncompliance Notice on Minimum Closing Price
Ginkgo Bioworks Receives Continued Listing Standard Notice From NYSE
William Blair Downgrades Ginkgo Bioworks Holdings to Underperform From Market Perform
Ginkgo Bioworks Holdings Q1 Loss Narrows, Revenue Drops; 2024 Revenue Outlook Slashed; Cost Cuts Planned
Ginkgo Bioworks Holdings, Inc. Updates Revenue Guidance for the Full Year 2024
Transcript : Ginkgo Bioworks Holdings, Inc., Q1 2024 Earnings Call, May 09, 2024
Earnings Flash (DNA) GINKGO BIOWORKS Posts Q1 Revenue $38M, vs. Street Est of $46M
Ginkgo Bioworks Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Ginkgo Bioworks Reports First Quarter 2024 Financial Results
Ginkgo Bioworks, GreenLab Launch Partnership to Produce Sugar Substitute Brazzein
GreenLab and Ginkgo Bioworks Announce New Partnership
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DNA Stock
  4. News Ginkgo Bioworks Holdings, Inc.
  5. Other languages